A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 214 participants.

Also called NCT05643508

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 214 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05643508
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05643508. Randomized; double masking; primary purpose treatment. Start 2023-02-23 (actual); primary completion 2024-09-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
Condition
Hypertension
Condition
Hyperlipidemias
Intervention (Drug)
(D) DWC202206
Intervention (Drug)
(D) DWC202207
Intervention (Drug)
(P) DWC202206
Intervention (Drug)
(P) DWC202207
Lead sponsor
Daewoong Pharmaceutical Co. LTD. (class: industry)

Record details

Record id
cardio:ct-nct05643508
Content hash
ccfcdc2121f15ef1c011821625e5b294874d74dd6f9b1f861349cd3ae8c51bc5